Flash glucose monitoring linked with lower HbA1c
The first large, real-world study also shows better awareness of hypoglycaemia in people with T1DM
An audit of a UK cohort using a flash glucose-monitoring system shows that the patients have lower HbA1c and are more aware of hypoglycaemia than they were before using the device.
The audit, instigated by the Association of British Clinical Diabetologists and funded by Abbott Diabetes Care, followed more than 10,000 users of the company’s FreeStyle Libre device at 102 public hospitals in the UK.
HbA1c measurements were available both before and after initiating flash glucose monitoring for 3182 participants (mean age 39.5, 53% female, BMI 25kg/m2, 98% with T1DM).
In these patients, HbA1c reduced from 8.3% prior to using the device to 7.8% after an average of 7.5 months of use.
